Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
The electronic aggregometer: A novel device for assessing platelet behavior in blood
1980 • 699 citations
Adenosine receptors: targets for future drugs
1982 • 681 citations
Adenosine and the concept of ‘retaliatory metabolites’
1984 • 422 citations
The control of the metabolism and the hormonal role of adenosine.
1978 • 416 citations
DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
1978 • 392 citations
Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitors
1977 • 376 citations
BATTERED BABIES—HOW MANY DO WE MISS?
1970 • 365 citations
Dipyridamole inhibition of adenosine metabolism in human blood
1983 • 263 citations
EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOUR
1965 • 244 citations
Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane
1974 • 224 citations
Influence of a Pyrimidopyrimidine Derivative on Deamination of Adenosine by Blood
1964 • 160 citations
Dipyridamole Inhibits Platelet Aggregation in Whole Blood
1983 • 143 citations
Regulatory functions of adenosine.
1987 • 129 citations
Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites
1982 • 102 citations
Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis
1984 • 94 citations
Dipyridamole kinetics
1982 • 89 citations
Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs
1973 • 89 citations
Diet and drugs in atherosclerosis.
1980 • 88 citations
The effect of dipyridamole on platelet function: correlation with blood levels in man.
1977 • 87 citations
Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: Possible explanation of mechanism of inhibition of platelet function
1975 • 71 citations
INCORPORATION OF ANALOG PURINE NUCLEOSIDES INTO THE FORMED ELEMENTS OF HUMAN BLOOD: ERYTHROCYTES, PLATELETS, AND LYMPHOCYTES*
1975 • 67 citations
Effects of coronary vasodilator drugs on the uptake and release of adenosine in cardiac cells
1979 • 66 citations
Blood Platelet Function and Medicinal Chemistry
1985 • 58 citations
Adenosine analogs and human platelets
1975 • 39 citations
Inhibition of lymphocyte function by 9-deazaadenosine
1983 • 39 citations
Methods for detection of hypersensitive platelets. Philadelphia, June 1977.
1978 • 37 citations
Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
1972 • 37 citations
Methods for Detection of Hypersensitive Platelets
1978 • 33 citations
The Effect of Pyrimidine Compounds on the Potentiation of Adenosine Inhibition of Aggregation, on Adenosine Phosphorylation and Phosphodiesterase Activity of Blood Platelets
1973 • 20 citations
Synergistic inhibition of platelet aggregation by forskolin plus PGE1 or 2-fluoroadenosine: Effects 2′,5′-dideoxyadenosine and 5′-methylthioadenosine
1982 • 20 citations
Transport of deoxycoformycin in human erythrocytes
1984 • 18 citations
Effects of dilazep on coronary and systemic hemodynamics in humans
1984 • 16 citations
5′-Methylthioadenosine and 2′ ,5′-dideoxyadenosine blockade of the inhibitory effects of adenosine on adp-induced platelet aggregation by different mechanisms
1980 • 14 citations
Effects of dilazep on human platelets and rat vascular tissue: In vitro studies on platelet aggregation, and arachidonic acid oxidation
1983 • 5 citations